Daewoong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 882.72 billion Korean Won [US$829.76 million]
of which 77%
Dong-A Socio Holdings Co Ltd
(726.17 billion Korean Won [US$682.60 million]
of which 67%
was Pharmaceutication), and
Daewoong Company Limited
(1.02 trillion Korean Won [US$954.11 million]
of which 114%
was Medicinal Manufacturing & Selling).
During the year ended December of 2016, sales at
Daewoong Pharmaceutical Company Limited were 883.92 billion Korean Won (US$830.89 million).
increase of 5.3%
versus 2015, when the company's sales were 839.69 billion Korean Won.
This was the fourth straight year of sales growth at Daewoong Pharmaceutical Company Limited.
Sales of Medicine Manufacturing&sale saw an increase
5.7% in 2016, from
839.82 billion Korean Won to 887.59 billion Korean Won.
Not all segments of Daewoong Pharmaceutical Company Limited experienced an increase in sales in 2016:
sales of Others fell 64.4% to 476.94 million Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).